Top Page
Nanoveu Ltd.
(Sydney:NVU)
Nanoveu Ltd. (NVU) vs. iShares MSCI Australia ETF (EWA)
Nanoveu Ltd. Business Overview & Revenue Model
Nanoveu Ltd. Financial Statement Overview
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 297.58K | 6.87K | 102.54K | 159.51K | 781.21K |
| Gross Profit | -2.23M | 10.53K | 25.27K | 72.37K | 386.56K |
| EBITDA | -7.45M | -2.73M | -1.98M | -2.45M | -1.97M |
| Net Income | -7.42M | -2.85M | -2.16M | -2.67M | -2.32M |
Balance Sheet | |||||
| Total Assets | 13.55M | 1.32M | 513.00K | 427.33K | 2.75M |
| Cash, Cash Equivalents and Short-Term Investments | 1.81M | 498.30K | 73.07K | 248.14K | 2.01M |
| Total Debt | 341.96K | 126.33K | 225.26K | 300.00K | 986.68K |
| Total Liabilities | 1.46M | 983.58K | 622.40K | 700.75K | 1.17M |
| Stockholders Equity | 12.31M | 374.94K | -109.41K | -273.41K | 1.58M |
Cash Flow | |||||
| Free Cash Flow | -5.92M | -2.10M | -2.01M | -2.82M | -2.04M |
| Operating Cash Flow | -5.85M | -2.10M | -2.01M | -2.82M | -2.04M |
| Investing Cash Flow | -287.31K | -258.66K | 0.00 | 0.00 | 0.00 |
| Financing Cash Flow | 7.44M | 2.53M | 1.83M | 142.12K | 2.91M |
Nanoveu Ltd. Technical Analysis
Nanoveu Ltd. Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
48 Neutral | AU$30.75M | -102.50 | -3.14% | ― | 2.98% | 93.55% | |
48 Neutral | AU$29.92M | -6.49 | -31.01% | ― | -3.43% | -40.65% | |
43 Neutral | AU$72.39M | -7.44 | ― | ― | ― | ― | |
43 Neutral | AU$24.21M | -10.38 | ― | ― | 7.32% | 67.11% | |
38 Underperform | AU$18.08M | -4.42 | -135.50% | ― | -48.98% | -12.82% | |
37 Underperform | AU$1.43M | -0.37 | ― | ― | ― | ― |
Nanoveu Ltd. Corporate Events
Nanoveu Limited has lodged its Appendix 4G and confirmed that its corporate governance statement for the year ended 31 December 2025 is available on its website, in accordance with ASX Listing Rules. The statement, approved by the board, details the extent to which Nanoveu follows the ASX Corporate Governance Council’s recommendations and identifies any departures and alternative practices.
The filing confirms that Nanoveu has key governance structures in place, including a board charter, appointment procedures for directors and executives, and defined accountability for the company secretary. By formally aligning its disclosures with ASX requirements, Nanoveu provides investors with greater transparency on its governance framework, which is a key consideration for compliance-focused and governance-sensitive shareholders.
The most recent analyst rating on (AU:NVU) stock is a Hold with a A$0.08 price target. To see the full list of analyst forecasts on Nanoveu Ltd. stock, see the AU:NVU Stock Forecast page.
Nanoveu Limited reported a sharp increase in revenue from ordinary activities to A$298,000 for the year ended 31 December 2025, representing a 4,230% rise on the prior year. Despite this growth, the company’s net loss attributable to members widened significantly to A$7.6 million, up 167% from 2024, with loss per share increasing to 0.92 cents.
The company’s net tangible assets per share improved to A$0.0016 from A$0.0007, reflecting some strengthening of the balance sheet even as it remains loss-making. Nanoveu expanded its corporate structure during the year, consolidating several new subsidiaries in Australia, Singapore and the U.S., and its audited financial statements received an unmodified opinion, while no dividends were declared for the period.
The most recent analyst rating on (AU:NVU) stock is a Hold with a A$0.08 price target. To see the full list of analyst forecasts on Nanoveu Ltd. stock, see the AU:NVU Stock Forecast page.
Nanoveu Limited has notified the market of the issue of 56,931,835 unquoted options, each exercisable at $0.15 and expiring on 27 January 2029. The options, which form part of previously announced transactions and are not intended to be quoted on the ASX, expand the company’s pool of unquoted equity securities and may influence future capital structure and potential dilution for existing shareholders if exercised.
The most recent analyst rating on (AU:NVU) stock is a Hold with a A$0.09 price target. To see the full list of analyst forecasts on Nanoveu Ltd. stock, see the AU:NVU Stock Forecast page.
Nanoveu Limited has applied to the ASX for quotation of 9,250,000 new ordinary fully paid shares under code NVU, with an issue date of 27 January 2026. The move increases the company’s quoted share capital, which may enhance liquidity in its stock and provides additional equity that could be used to support future corporate or funding activities, although no further operational or strategic context is provided in the filing.
The most recent analyst rating on (AU:NVU) stock is a Hold with a A$0.09 price target. To see the full list of analyst forecasts on Nanoveu Ltd. stock, see the AU:NVU Stock Forecast page.
Nanoveu Limited has applied for quotation on the ASX of 83,863,637 new fully paid ordinary shares, with an issue date of 27 January 2026. The additional securities, which stem from previously announced transactions, will expand the company’s quoted share base and may enhance liquidity in its stock, potentially supporting future capital access and market visibility for the technology-focused issuer.
The most recent analyst rating on (AU:NVU) stock is a Hold with a A$0.09 price target. To see the full list of analyst forecasts on Nanoveu Ltd. stock, see the AU:NVU Stock Forecast page.
Nanoveu Limited has completed the main tranche of its previously announced strategic placement, raising $7.38 million before costs via the issue of 83.9 million new shares at $0.088 each, accompanied by 41.9 million attaching options, within its existing ASX placement capacity, and has also issued 9.25 million shares following the exercise of unlisted options. The remaining $120,000 component to directors will be finalised subject to shareholder approval, while the company has confirmed that the new securities were issued without a prospectus under the Corporations Act’s disclosure exemptions and that it remains compliant with its continuous disclosure and reporting obligations, bolstering its capital base for ongoing operations and growth initiatives in its semiconductor, 3D content and materials businesses.
The most recent analyst rating on (AU:NVU) stock is a Hold with a A$0.09 price target. To see the full list of analyst forecasts on Nanoveu Ltd. stock, see the AU:NVU Stock Forecast page.
Nanoveu Limited has notified the ASX of a proposed capital raising involving the issue of up to 85,227,274 new fully paid ordinary shares and 57,613,637 options, each with an exercise price of $0.15 and expiring in January 2029. The securities are to be issued by way of a placement or other form of issue, with a proposed issue date of 27 January 2026, signalling a move to strengthen the company’s balance sheet and potentially fund future corporate or operational initiatives, which may affect existing shareholders through dilution while providing additional capital to support Nanoveu’s strategic objectives.
The most recent analyst rating on (AU:NVU) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on Nanoveu Ltd. stock, see the AU:NVU Stock Forecast page.
Nanoveu has secured firm commitments to raise A$7.5 million via an upsized share placement at A$0.088 per share, with free attaching options, from new and existing sophisticated and institutional investors, with directors also participating subject to shareholder approval. The funds will strengthen the balance sheet and accelerate commercialisation of EMASS’s ECS-DoT edge-AI semiconductor platform—supporting the 16nm tape-out process now progressing through TSMC/IMEC workflows, live drone validation of its endurance gains following strong simulation results, as well as broader go-to-market initiatives, international sales expansion, and further development of EyeFly3D and nanocoating technologies, positioning Nanoveu for faster global expansion and deeper engagement with OEMs and system integrators.
The most recent analyst rating on (AU:NVU) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on Nanoveu Ltd. stock, see the AU:NVU Stock Forecast page.
Nanoveu Limited has requested an immediate trading halt in its securities on the ASX as it prepares to announce details of a proposed capital raising. The halt will remain in place until either the start of normal trading on 20 January 2026 or the release of the capital-raising announcement, with the company indicating it is not aware of any reasons the halt should not be granted, signalling a potentially significant funding move that may affect its capital structure and investor positioning.
The most recent analyst rating on (AU:NVU) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on Nanoveu Ltd. stock, see the AU:NVU Stock Forecast page.
Nanoveu Limited has issued 250,000 new ordinary shares following the exercise of unlisted options, modestly expanding its share capital. The company confirmed the shares were issued without a prospectus in reliance on provisions of the Corporations Act, stating it remains compliant with its reporting obligations and that there is no excluded information, signalling a routine capital management move with limited immediate operational impact but incremental funding flexibility for its advanced technology portfolio.
The most recent analyst rating on (AU:NVU) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on Nanoveu Ltd. stock, see the AU:NVU Stock Forecast page.
Nanoveu Limited has applied to the ASX for the quotation of 250,000 new fully paid ordinary shares under the code NVU, with an issue date of 14 January 2026. The securities arise from the exercise or conversion of existing options or other convertible instruments, modestly increasing the company’s quoted share capital and potentially enhancing liquidity for investors.
The most recent analyst rating on (AU:NVU) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on Nanoveu Ltd. stock, see the AU:NVU Stock Forecast page.
Nanoveu Ltd has applied to the ASX for quotation of 6,026,923 new fully paid ordinary shares, to be traded under its existing ticker NVU. The new securities, issued on 24 December 2025 following the exercise or conversion of existing options or other convertible instruments, will expand the company’s quoted share base and marginally increase its access to equity capital, with implications for existing shareholders’ dilution and market liquidity.
Nanoveu Limited has issued 6,026,923 new ordinary shares following the exercise of unlisted options, expanding its share capital without a separate disclosure document under Australia’s Corporations Act. The company confirmed it is compliant with its continuous disclosure and financial reporting obligations and that there is no excluded information, signalling a routine capital management move that modestly strengthens its equity base while maintaining regulatory transparency for investors.
Nanoveu Limited has announced an investor webinar to discuss the advancements of its subsidiary, EMASS, in ultra-low-power ECS-DoT system-on-chip (SoC) technologies. The webinar will highlight significant milestones such as the tape-out of a new integrated circuit on TSMC’s 16nm FinFET, collaborations with Arrow Electronics and Semtech, and the establishment of a sales network for ECS-DoT solutions. These developments are expected to enhance Nanoveu’s market positioning and offer scalable AI capabilities across various industries.
Nanoveu Limited’s subsidiary, Embedded A.I. Systems Pte. Ltd (EMASS), has reached a significant milestone with its 16nm ECS-DoT AIoT system-on-chip (SoC), completing the front-end, synthesis, and physical design stages. This development positions Nanoveu at the forefront of ultra-low-power Edge AI technology, integrating advanced features such as on-chip Bluetooth Low Energy, expanded on-chip memory, and enhanced AI acceleration, which collectively promise to improve energy efficiency and reduce costs for connected devices.
Nanoveu Limited announced an amendment to its previous ASX announcement regarding its collaboration with EMASS and Semtech on low-power edge AI. The amendment involved the removal of an incorrectly displayed Semtech logo, with no new material information affecting the release. This collaboration enhances Nanoveu’s portfolio, positioning it as a key player in the rapidly growing 3D content, AI, and edge computing markets.